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SUMMARY
The objective of the present study was to evaluate the serum viral load in chronically infected Hepatitis B virus (HBV) patients 
and to investigate the distribution of HBV genotypes in São Paulo city. Quantitative HBV-DNA assays and HBV genotyping have 
gained importance for predicting HBV disease progression, have been employed for assessing infectivity, for treatment monitoring 
and for detecting the emergence of drug resistance. Twenty-nine Brazilian patients with suspected chronic hepatitis B were studied, 
using real time PCR for viral load determination and direct DNA sequencing for the genotyping. The serology revealed chronic 
HBV infection in 22 samples. The HBV-DNA was positive in 68% samples (15/22). The phylogenetic analysis disclosed that eleven 
patients were infected with HBV genotype A, two with genotype F and two with genotype D. Thus, the genotype A was the most 
prevalent in our study.
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INTRODUCTION
Hepatitis B virus (HBV) infects 400 million people worldwide8,9, 
with a particularly high prevalence in Asia and Africa. HBV is the most 
common cause of liver disease worldwide14,22 being a global health 
problem7. Some patients may be affected only mildly9,22, while other 
patients may evolve to cirrhosis, hepatocellular carcinoma8, and death 
from chronic hepatitis B19.
HBV molecular virology and immunology were found to be more 
complex than initially thought, whereas the selection of precore HBV 
mutants was showed to be largely determined by the HBV genotype5. 
Several studies found an association between variants of the virus and 
genetic variations found in the host. However, only recently the impact 
of natural variability of the virus on the clinical course of disease has 
become the focus of research17.
In Latin America there are more than 140,000 acute cases of hepatitis 
B per year and about 6.6 to 12 million people are chronic HBV carriers. 
More than 65% of these cases live in South America, where about 100,000 
cases of acute hepatitis B occur annually2. In Brazil, there are more than 
75,000 acute cases per year and HBsAg prevalence increases from South 
to North: 1% in the Southern and Central Western regions; 2% in the 
Southeastern region; 2.5% in the Northeastern region, and 8% in the 
Northern region. However, moderate to elevated HBsAg prevalence has 
been detected in candidate blood donors from the Southern states Santa 
Catarina (4.3%) and Paraná (8.3%)2.
HBV genotypes have a distinct geographical distribution11,19. There 
are eight major HBV genotypes (A to H) prevailing in different parts of 
the world. Genotyping A is pandemic8,20, B and C are commonly found 
in east Asia, and the latter has been associated with an increased risk of 
hepatocellular carcinoma19. Genotype D has been found worldwide with 
highest prevalence in Mediterranean area, Middle East and South Asia, 
particularly in India. The genotyping E is found in sub-Saharan Africa, 
F in South and Central America, G in France and in USA1,12. Genotype 
H so far seems to be restricted to Northern Latin America12. Coinfection 
with several HBV genotypes seems to be rare, below 5%19.
In Brazil, the genotype A is the most prevalent and the genotypes B, 
C, D, and F have already been reported. Their distribution varies among 
Brazilian regions suggesting an influence of the immigration pattern for 
each region18.
The objective of the present study was to evaluate the serum viral 
load and the virus genotype in chronically infected Hepatitis B virus 
(HBV) patients. The phylogenetic analysis disclosed that eleven patients 
were infected with HBV genotype A, two with genotype F and two with 
genotype D. Therefore, the genotype A was the most prevalent in our 
study in São Paulo city.
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MATERIALS AND METHODS
Blood samples: A total of 29 blood samples of patients with 
suspected chronic hepatitis B were collected. The serum was collected 
before the beginning of the antiviral treatment and stored at -70 °C. Age, 
sex and risk factors were obtained for infection with HBV and the time 
of infection estimated for patients with risk factors for blood transfusion 
and vertical transmission. The study protocol was approved by the Ethical 
Committee of the Institute of Infectious Diseases “Emílio Ribas” and 
written informed consent was obtained from all patients.
DNA extraction, Viral load determination, Nested-PCR and 
Sequencing: To detect hepatitis B viral DNA in the serum, HBV-DNA 
was isolated from 200 µL of serum using extraction method QIAamp 
DNA Blood Mini Kit (Qiagen, Germany) according to the manufacturers’ 
protocol. Conventional PCR was carried out to amplify a 239 bp of 
DNA fragment. 
HBV-DNA was quantified by TaqMan technology based real time 
PCR (quantitative polymerase chain reaction (qPCR)) as described by 
GARSON et al.4, including albumen as positive control. Reactions were 
analyzed by Bio-Rad iCycler IQ Real Time PCR (Hercules, CA, USA). 
To test the performance of our primers and probes in real time PCR, we 
used 106, 105, 104, 103, 102, and 10 copies of HBV-DNA. Our results 
showed that amplification performance was good for all reactions. 
Positive samples were amplified by conventional PCR for posterior 
genotyping. Polymerase chain reaction (PCR) and nested-PCR have been 
described by KANEKO et al.6.  The HBV PCR products were sequenced 
utilizing ABI Prism Big Dye Terminator Ready Reaction Kit version 3.0 
(Applied Biosystems, Foster City, CA). Reactions were analyzed by ABI 
Prism 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA). 
Sequences were validated after visual inspection and analysis using the 
Sequencher program version 4.0.5 (Gene Codes).
Phylogenetic analysis: The fifteen sequences with 239 base pairs 
from precore region generated (Table 1) were manually aligned with 21 
reference sequences from genotypes A to H. The GenBank accession 
numbers for the reference sequences were: AY128092, X51970, 
AB241114, D00329, AB010289, X04615, AY123041, AB014381, 
M32138, X85254, X75657, AB032431, X69798, AB036910, AF223965, 
AF160501, AB064310, AF405706, AY090454, AY090457, AY090460.
Phylogenetic analyses were performed using both maximum 
likelihood (ML) criterion and Bayesian inference. ML searches were 
performed using GARLI v0.951.OsX-GUI21 under an assumed general 
time-reversible (GTR) model with rates estimated from the data. Three 
independently runs were performed. Each run gave identical topologies 
and similar likelihood scores. The Bayesian analysis was performed 
with MrBayes16 using a GTR + invariant (ι) and gamma (Γ4). The 
MCMC search was run for 2 x 106 generations with trees sampled every 
100th generation (with a burn-in of 10%). The final tree presented is the 
maximum clade credibility tree inferred using TreeAnnotator v1.4.7 
(available from http://beast.bio.ed.ac.uk) from the 1800 trees estimated 
by MrBayes.
RESULTS
A total of twenty-nine Brazilian patients with suspected chronic 
hepatitis B were studied. The serology revealed that 22 had HBsAg 
detection after six months from the first positive sample. HBV-DNA 
was positive in 68% samples (15/22), eight women and seven men, 
with a mean age of 42 years (range 31-51) and the HBV genotype was 
determined in 15 of 15 samples which presented detectable viral load 
(Table 1). In seven cases, the HBV-DNA viral load was undetectable by 
quantitative PCR; the cause of no amplification was low DNA serum viral.
Table 1 
 HBV viral load, conventional PCR and serology of the HBV
Patient ID Gender Age (years) HBV viral load HBV subtype Accession number Serology HBsAg Serology anti-HBs
01 M NC 3370 A FJ404688 >250,000 / 0.05 Neg
02 M 34 *>500000 F FJ404679 >250,000 / 0.05 Neg
03 M 51 1950 A FJ404690 >250,000 / 0.05 Neg
04 F 39 3130 A FJ404686 >250,000 / 0.05 Neg
05 F NC 184 F FJ404680 >250,000 / 0.05 Neg
06 F NC 11200 A FJ404682 >250,000 / 0.05 Neg
07 F 45 30780 A FJ404685 >250,000 / 0.05 Neg
08 F 39 6450 D FJ404691 >250,000 / 0.05 Neg
09 F NC 18800 A FJ404687 >250,000 / 0.05 Neg
10 M 53 67200 D FJ404693 >250,000 / 0.05 Neg
11 M 48 259 A FJ404684 0.844 / 0.05 Neg
12 F 45 3390 A FJ404683 >250,000 / 0.05 Neg
13 F 31 461 A FJ404681 >250,000 / 0.05 Neg
14 M 40 *>500000 A FJ404692 >250,000 / 0.05 Neg
15 M 51 282 A FJ404689 >250,000 / 0.05 Neg
M: Male; F: Female; NC: not collected; Plasma DNA-HBV viral load: copies/mL; *> upper limit of the assay; Neg: Negative; Kit HBsAg Architect (Abbott, USA); 
Kit anti-HBs Murex (Dartford, England)
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The phylogenetic analysis disclosed that eleven patients were infected 
with HBV genotype A (73.3%), two with genotype F (13.3%) and two 
with genotype D (13.3%), as shown on Fig. 1. Therefore, the genotype 
A was the most prevalent in our study in São Paulo city.
DISCUSSION
HBV genotyping among chronic carriers was studied in São Paulo 
city. This small sample had a mean age of 42 years, and was made up 
predominantly of females. In the city of Salvador, Brazil, the majority 
of the cases corresponded to males, with a similar distribution age 
(30 to 40 years)15. Viral load was detected in fifteen samples, and two 
patients had viral load that were above the upper limit of detection. To 
our knowledge, this is the first study to describe HBV viral load done 
with Brazilian subjects.
Clinical studies have shown a high rate of HBV-DNA in chronic 
cases7. Quantitative HBV-DNA assays and HBV genotyping have 
gained importance for predicting HBV disease progression, employed 
for assessing infectivity, for treatment monitoring and for detecting the 
emergence of drug resistance4,19. A study showed that viral load is the 
major determinant of the risk of liver cirrhosis, hepatocellular carcinoma 
and death in chronic hepatitis B patients19. 
 To our knowledge, this is the first time that HBV genotypes from 
patients living in São Paulo were typed. The genotypes showed a distinct 
and well-defined geographic distribution. In our study, genotype A was 
the most prevalent, but other subtypes were also typed, such as F and 
D. This distribution was similar to that found in Rio de Janeiro and 
Salvador, for example13,15. The higher prevalence of HBV genotype A 
might reflect the ethnic background of the Brazilian population, with its 
strong miscigenation15. The white population of São Paulo is descendant 
of Portuguese and other Europeans, predominantly Italians. Other studies 
have also shown that genotype A is most commonly found in North 
America, Africa and Northwestern Europe15 and is the most prevalent 
in Brazil followed by genotypes B, C, D and F18 as already documented 
among most other groups of chronic carriers, excluding hemodialysis 
patients3.
In the Amazonian region, only genotype F was found among the 
native Brazilian tribes who have not had contact with whites, while 
genotype A was found among tribes with frequent contacts13. In a study 
Fig. 1 - A) Frequency of genotypes found in 15 Brazilian HBV patients studied in São Paulo city. B) Maximum clade credibility tree based on 239 base pairs from pre-core region. The posterior 
probability values are shown for key nodes.
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from MAYERAT et al.10, it was suggested that the infection by HBV 
genotype A could be more frequently associated with chronic infection 
than genotype D. HBV genotype D has a universal distribution, however 
it seems to be more prevalent in Southern Europe, Middle East, Northern 
Africa and India15.
Finally, for the first time the HBV genotype was performed in samples 
from patients living in São Paulo city. The HBV-DNA viral load was 
performed for clinical samples to follow up the patients. Viral load is 
a major marker of disease progression and for treatment guidelines. 
Summing up, quantitative real time PCR was a simple, sensitive, specific 
and reproducible assay for the measurement of HBV viral load in serum 
samples.
RESUMO
Distribuição dos genótipos do vírus da hepatite B e níveis de carga 
viral em pacientes brasileiros cronicamente infectados na cidade 
de São Paulo
O objetivo do presente estudo foi avaliar a carga viral no soro de 
pacientes cronicamente infectados pelo vírus da Hepatite B (HBV) e 
investigar a distribuição de genótipos HBV na cidade de São Paulo. PCR 
quantitativo do HBV e genotipagem ganharam importância para a previsão 
de progressão da doença, empregada para avaliar a infectividade, para 
tratamento e acompanhamento e para detectar o aparecimento de resistência 
aos anti-retrovirais. Vinte e nove pacientes brasileiros com suspeita de 
hepatite B crônica foram estudados, utilizando PCR em tempo real para 
a determinação da carga viral e seqüenciamento direto para determinação 
do genótipo. A sorologia revelou que 22 estavam, de fato, cronicamente 
infectados pelo HBV. O HBV-DNA foi positivo em 68% das amostras 
(15/22). Em sete casos, HBV-DNA foi indetectável por PCR quantitativo. 
A análise filogenética mostra que onze pacientes foram infectados com 
hepatite B genótipo A, dois com genótipo F e dois com genótipo D. Desta 
forma, o genótipo A foi o mais prevalente em nosso estudo.
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